Wound News and Research

RSS

A valuable guide for diabetic patients

McCord Research, Inc., founded by Darlene McCord, Ph.D., FAPWCA, has produced a valuable guide to help people with diabetes take care of their feet for a lifetime. Dr. McCord has over 30 years of experience in the skin and wound care industry. Ten years ago she also created the most successful skin and wound care product line in North America.

27 Dec 2013

Researchers study health consequences of RTE proliferation that occurs in aging tissues

The genomes of organisms from humans to corn are replete with "parasitic" strands of DNA that, when not suppressed, copy themselves and spread throughout the genome, potentially affecting health. Earlier this year Brown University researchers found that these "retrotransposable elements" were increasingly able to break free of the genome's control in cultures of human cells.

27 Dec 2013

Research review examines effectiveness of treatments for chronic skin wounds

A systematic review of 66 research papers focused on the treatment of skin ulcers suggests that most are so technically flawed that their results are unreliable. And even of those that pass muster, there is only weak evidence that some treatments work better than standard compression therapy or special stockings.

24 Dec 2013

Exposure to images of modified vulvas can significantly influence women's perceptions

Women's perceptions of what is considered normal and desirable female genitalia may be influenced by exposure to modified images, suggests a new study published today (20 December) in BJOG: An International Journal of Obstetrics and Gynaecology.

23 Dec 2013

Intrexon enters into definitive agreement to acquire Medistem

Intrexon Corporation, a leader in synthetic biology, today announced that it has entered into a definitive agreement to acquire, for approximately $26 million, San Diego-based Medistem, Inc. a pioneer in the development of Endometrial Regenerative Cells, universal donor adult stem cells that stimulate new blood vessel formation and are capable of generating different tissues including heart, brain, pancreas, liver, bone, cartilage and lung.

21 Dec 2013

Researchers map cell's complex genetic interactions to fix UV damaged DNA

Researchers at the University of California, San Diego School of Medicine, with colleagues in The Netherlands and United Kingdom, have produced the first map detailing the network of genetic interactions underlying the cellular response to ultraviolet (UV) radiation.

19 Dec 2013

Decreasing levels of reactive oxygen species can break cycle of unhealing wounds

Chronic wounds affect an estimated 6.5 million Americans at an annual cost of about $25 billion. Further, foot blisters and other diabetic ulcers or sores account for the vast majority of foot and leg amputations in the United States today.

18 Dec 2013

Skin cells can migrate over regions devoid of support from extracellular matrix

A team of researchers from the National University of Singapore have discovered that outer skin cells are able to unite to form suspended "bridges" during wound healing. The new findings will pave the way for tissue engineering, such as the design of artificial skin, and better wound treatment.

13 Dec 2013

ACS, BCBSIL and Northwestern Medicine join to improve quality of surgical care in Illinois

The Illinois chapters of the American College of Surgeons (ACS), Blue Cross and Blue Shield of Illinois (BCBSIL), and Northwestern Medicine- have come together to offer selected hospitals across Illinois the opportunity to join the Illinois Surgical Quality Improvement Collaborative (ISQIC), a three-year effort to improve the safety and quality of surgical care in Illinois.

13 Dec 2013

New treatment options for diabetic wound healing in cornea and skin

Diabetes Mellitus (DM), a metabolic disorder that affects nearly 170 million people worldwide, is characterized by chronic hyperglycemia that disrupts carbohydrate fat and protein metabolism resulting from defects in insulin secretion, insulin action or both. DM can cause long-term damage, dysfunction and even failure of various organs.

13 Dec 2013

U.S. Marines investigate association between traumatic brain injury and risk of PTSD

In a novel study of U.S. Marines investigating the association between traumatic brain injury (TBI) and the risk of post-traumatic stress disorder (PTSD) over time, a team of scientists led by researchers from the Veterans Affairs San Diego Healthcare System and University of California, San Diego School of Medicine report that TBIs suffered during active-duty deployment to Iraq and Afghanistan were the greatest predictor for subsequent PTSD, but found pre-deployment PTSD symptoms and high combat intensity were also significant factors.

12 Dec 2013

Equations help explain key parameters of stents that combat artherosclerosis

Coronary heart disease accounts for 18% of deaths in the United States every year. The disease results from a blockage of one or more arteries that supply blood to the heart muscle.

9 Dec 2013

Adocia gets development and commercialization rights in nanotechnology for drug delivery

Adocia, a biotechnology company specializing in the development of ‘best-in-class’ medicines from already approved therapeutic proteins, announces today the signature of an exclusive license agreement with the CNRS, the University Bordeaux I, the Institut Polytechnique de Bordeaux and Aquitaine Science Transfert.

9 Dec 2013

‘Flesh-eating’ disease treatments: an interview with Dr. John Crew, Seton Medical Center

Untreated, the mortality probably exceeds 70%. Flesh eating is a description of Toxic Inflammatory Cellulitis which usually starts by bacterial subcutaneous infection followed by freezing in phase II healing which is inflammatory.

9 Dec 2013

Gecko Biomedical announces closing of Series A financing round

Gecko Biomedical, a privately owned medical device company based in Paris that is developing novel biodegradable surgical wound closure solutions, announced the closing of a €8 million ($11m) Series A financing round. The financing was co-led by Omnes Capital and CM-CIC Capital Finance, and joined by CapDecisif Management.

9 Dec 2013

Osiris: CMS releases proposed ruling for reimbursement of skin substitutes in hospital outpatient setting

Osiris Therapeutics, Inc., the leading stem cell company focused on developing and marketing products in orthopedics, sports medicine and wound care, announced today that, on November 27, 2013, the Centers for Medicare and Medicaid Services released their proposed ruling for the reimbursement of skin substitutes in the hospital outpatient setting. CMS decided to package the reimbursement for products used in advanced wound care with the related surgical procedure into a two-tier system.

30 Nov 2013

American scientists introduce novel gel for sealing wounds

In first-aid situations, wounds must be quickly and effectively closed to stop blood loss and prevent infection. For treatment on arrival in a hospital, the temporary seal must be reopened, which often causes additional damage to the injured tissue. In the journal Angewandte Chemie, American scientists have now introduced a novel gel for sealing wounds. The gel can later be dissolved and gently removed.

28 Nov 2013

Current laser therapy approaches provide effective treatment for excessive scars

Current laser therapy approaches are effective for treating excessive scars resulting from abnormal wound healing, concludes a special topic paper in the December issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

27 Nov 2013

Troubled effort to devise new cholesterol guidelines

The New York Times explores what went wrong as a group of doctors struggled to find common ground on how heart issues should be treated. Other stories also look at consumer frustration about a landmark settlement on hip implants and concerns being reviewed by the FDA about emergency contraceptive pills.

27 Nov 2013

EPCs: A promising therapy for type 1 diabetes

Pancreatic islet transplantation is a promising therapy for treating type 1 diabetes, but the majority of transplanted cells die soon after they are transplanted.

27 Nov 2013

Wound News and Research

A valuable guide for diabetic patients

Researchers study health consequences of RTE proliferation that occurs in aging tissues

Research review examines effectiveness of treatments for chronic skin wounds

Exposure to images of modified vulvas can significantly influence women's perceptions

Intrexon enters into definitive agreement to acquire Medistem

Researchers map cell's complex genetic interactions to fix UV damaged DNA

Decreasing levels of reactive oxygen species can break cycle of unhealing wounds

Skin cells can migrate over regions devoid of support from extracellular matrix

ACS, BCBSIL and Northwestern Medicine join to improve quality of surgical care in Illinois

New treatment options for diabetic wound healing in cornea and skin

U.S. Marines investigate association between traumatic brain injury and risk of PTSD

Equations help explain key parameters of stents that combat artherosclerosis

Adocia gets development and commercialization rights in nanotechnology for drug delivery

‘Flesh-eating’ disease treatments: an interview with Dr. John Crew, Seton Medical Center

Gecko Biomedical announces closing of Series A financing round

Osiris: CMS releases proposed ruling for reimbursement of skin substitutes in hospital outpatient setting

American scientists introduce novel gel for sealing wounds

Current laser therapy approaches provide effective treatment for excessive scars

Troubled effort to devise new cholesterol guidelines

EPCs: A promising therapy for type 1 diabetes

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News